All Vaccinology articles
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsNanoparticle vaccine candidate shows promise against emerging tick-borne virus
Researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that has no prevention, treatment or cure.
-
CareersIgnoring the rise of anti-science could usher back once-deadly diseases
As a wave of anti-science sentiment sweeps the globe, scientists need to speak up, says paediatic vaccine scientist Dr Peter Hotez in an interview with The Microbiologist as he launches his new book.
-
NewsClinical trial of HIV vaccine begins in United States and South Africa
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people. Source: NIAID Transmission electron micrograph ...
-
NewsRapid acting oral vaccines are on the way
Researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.
-
NewsMpox infections less severe in those vaccinated or previously infected
A new study has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the importance and effectiveness of vaccination.
-
NewsThousands of children’s operations ’will have to be cancelled’ this winter as UK government delays RSV vaccine
Babies could be needlessly hospitalised this winter because the government has delayed a vaccine that protects them from a life-threatening virus, the UK’s top children’s doctor has warned.
-
NewsStudy reveals how leishmaniasis vaccines work at molecular level
Researchers have determined how these vaccine candidates for leishmaniasis prompt molecular-level changes in host cells that have specific roles in helping generate the immune response.
-
NewsMap the coronavirus spike protein for insight into vaccine development
A new study has found that the fusion peptide in the spike protein plays a more invasive role in fusing the virus to the cell than previously thought, which is significant in understanding how infection occurs.
-
NewsStudy helps explain SARS-CoV-2 variants’ rapid spread
Omicron variants, which circulated quickly around the globe, bind to cells more avidly and evade antibodies more efficiently than earlier variants, new research reveals.
-
NewsTexas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
NewsAttack on Mac1 Covid protein may lead to longer lasting live-attenuated vaccine
Research could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
-
FeaturesUnder the microscope: Japanese encephalitis
JEV is one of the leading causes of viral encephalitis globally, widespread across Asia-Pacific and endemic in 24 countries of south and southeast Asia.
-
NewsResearchers on cusp of a new vaccine modality breakthrough
Researchers have succeeded in developing a new vaccine modality that is a stable particulate vaccine. The new vaccine modality is at proof-of-concept stage and in early development.
-
-
NewsBooster shot being developed to fight koala Chlamydia
Researchers are developing a booster vaccine using implant technology in the fight against the deadly Chlamydia disease that has decimated koala colonies.
-
NewsNew VDEC is ‘step change’ for UK’s growing vaccine capabilities
The UK Health Security Agency has unveiled its world-leading Vaccine Development and Evaluation Centre at Porton Down, which will be at the forefront of the UK’s ability to develop vaccines against the world’s deadliest pathogens.
-
OpinionNew RSV vaccines on the way - so what do we do about vaccine hesitancy?
Not one, but two promising new vaccines are likely to be introduced to the UK, yet routine childhood vaccination rates have been decreasing for ‘old’ diseases like measles and polio - what’s going on?
-
NewsModerna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
NewsCOVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
